source
- GSK signs $1 billion siRNA partnership with China's SiranBio to target obesityGSK is expanding its cardiometabolic portfolio by entering a new collaboration with Chinese biotech SiranBio. The agreement is valued at $1 billion in biobucks and focuses on developing siRNA ther…
- Eli Lilly to invest $4.5 billion in new manufacturing facilities across IndianaEli Lilly announced a $4.5 billion allocation for new manufacturing projects in Indiana. The company said the funds will be used to build and upgrade production sites across the state, expanding it…